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Brachial-ankle Pulse Wave Velocity As A Risk Stratiﬁcation Index For The Short-
term Prognosis Of Patients With Established Coronary Artery Disease
Sang Yeub Lee, sang min Kim, Jang-Whan Bae, Kyung-Kuk Hwang, Dong-Woon Kim,
Myeong-Chan Cho
Chungbuk Regional cardiovascular center, Cheongju-Si, Korea, Republic of
BACKGROUND AND OBJECTIVES Pulse wave velocity (PWV) is an index of arterial
stiffness and surrogate marker of subclinical cardiovascular disease. The clinical
application of baPWV in patients with established coronary artery disease (CAD) re-
mains unclear.
SUBJECTS (MATERIALS) AND METHODS We evaluated that brachial-ankle pulse wave
velocity (baPWV), a marker for arterial stiffness can be a risk stratiﬁcation index to
predict prognosis in patients with established CAD. We recruited the patients un-
dergoing emergent or elective CAG and PCI for stable angina or acute coronary
syndrome (non-ST-elevation and ST-elevation myocardial infarction, unstable
angina). The main outcome measures were cardiovascular (CV) death, deﬁnite/
probable stent thrombosis (ST), nonfatal myocardial infarction (MI), coronary
revascularization (PCI or CABG) and a composite end point of ischemic events.
PWV was determined using an automatic volume-plethysmographic device, form
PWV/ABI.
RESULTS In total, 925 patients were enrolled (Male 670, 72.4%) with median follow-
up of 524 days. All patients received optimal antiplatelet therapy and proper coronary
intervention. The higher baPWV was deﬁned as a median baPWV of 1730 cm s-1 or
more. The patients were diagnosed as ST elevation myocardial infarction (221, 23.0%),
non ST elevation myocardial infarction (221, 23.9%), unstable angina (294, 31.8%),
stable angina (189, 20.4%). The composite end points of the study at follow-up of 12
months were cardiovascular death, nonfatal myocardial infarction (MI), and coronary
revascularization. At a 12-month follow-up, we found 61 total ischemic events (higher
PWV 7.9% vs normal PWV 5.8% (p¼0.211)), 18 cardiovascular deaths (2.0% vs 1.9%
(p¼0.964)), 5 nonfatal MIs (0.8% vs 0.4% (p¼0.319)), 3 stent thrombosis (0.6% vs
0.3% (p¼0.313)) and 45 target-vessel revascularizations (5.9% vs 4.2% (p¼0.241)). In
survival analysis, there was no signiﬁcant difference between patient with higher
baPWV and normal velocity. Multivariate analysis revealed that a higher baPWV was
not signiﬁcantly associated with poorer short-term prognosis (hazard ratio, 0.793;
95% conﬁdence interval, 0.529-1.188) in established CAD patients.
CONCLUSIONS baPWV, a marker for arterial stiffness, is not a risk stratiﬁcation index
for short-term prognosis in patients with established CAD patients. Routine use of
PWV to predicting future cardiovascular events in patients with established CAD
seems to be unnecessary.
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The Impact of Monthly Multidisciplinary Formalized Data Feedback on Treatment
Times and Outcomes in ST Elevation Myocardial Infarction
Hayder D. Hashim, Atish Mathur, Adam Raskin, Subbaro Boppana, james maher,
Christine Gerula, Marc Kalpholz
Rutgers University-New Jersey Medical School, Springﬁeld, NJ
BACKGROUND We have previously reported signiﬁcant reductions in door-to-balloon
(D2B) and recognition-to-reperfusion (R2R) times by use of a fully automated wireless
network that transmits 12-lead ECG of patients with suspected ST elevation
myocardial infarction (STEMI) from emergency medical services (EMS) personnel in
the ﬁeld to smartphones worn by cardiologists (STAT-MI pathway). We now report
the effect of monthly multidisciplinary formalized data feedback on treatment times
in STEMI patients who presented through other non-automated STEMI pathways
(“walk-in” and un-networked EMS ambulances).
METHODS Prospective data on demographics, cardiac biomarkers, left ventricular
ejection fraction (LVEF) and all-cause mortality was collected in 147 who presented
through non STAT-MI pathway (“walk-in” and un-networked EMS) between June
2006 to May 2013. D2B, R2R, Total ischemic (TI), door-to-ﬁrst ECG (D2ECG) and door-
to-cardiac catheterization laboratory (D2LAB) times were discussed during monthly
multidisciplinary meetings at our institution using a formalized date feedback spread
sheets. Total study period was 84 months and data was analyzed by quarters.
RESULTS Between the 1st and 4th quarters median D2B time decreased signiﬁcantly
from 130 to 78.5 minutes (p<0.0001); the median D2ECG time decreased from 25 to 9.5
minutes (p¼0.02) and median D2LAB time decreased from 101 to 41.5 minutes
(p<0.0001). Post STEMI LVEF increased from 35  12 % to 53  14 % (p¼0.009) be-
tween 1st and 4th quarters. ECG Selvester score for estimating infarct size decreased
from 10.82  4.8 to 5.06  4.5 (p < 0.001).
The survival trend analysis showed improvement in survival rates from 0.70 to
0.90 (p¼0.04). Based on cox proportional hazards model the D2B time (HR1.006, p ¼
0.002), peak troponin (HR 1.004, p ¼ 0.04), hypertension (HR 5.75, p ¼ 0.02) and age
(HR 1.04, p ¼ 0.01) were strong independent predictors of mortality.
CONCLUSION Monthly formalized data feedback and detailed multidisciplinary
analysis of all STEMI presenters at our institution had resulted in signiﬁcant reduc-
tion in treatment times and improved outcomes. A Halo effect that extended from our
previously reported STAT-MI pathway.CRT-166
Gender Based Differences In Presentation And Outcomes Of Vascular
Brachytherapy For Drug Eluting Stent Failure
Smita I. Negi, Romain Didier, Sarkis Kiramijyan, Edward Koifman, Nevin Baker,
Ricardo O. Escarcega, Itsik Ben-Dor, William O. Suddath, Augusto D. Pichard,
Lowell F. Satler, Ron Waksman
Medstar Washington Hospital Center, Washington DC, DC
BACKGROUND Drug eluting stent in-stent restenosis (DES-ISR) has a high recurrence
rate in spite of repeat balloon angioplasty or additional DES. Vascular brachytherapy
(VBT) is an option for refractory DES-ISR. However, it is unknown if there are gender-
based differences in presentation and outcome of recurrent DES-ISR treated with
VBT. This study aimed to report the gender-based differences in the baseline char-
acteristics and clinical outcomes of DES-ISR treated with VBT.
METHODS Patients undergoing VBT for DES-ISR were enrolled from an ongoing PCI
registry. Demographic, clinical and procedural data were collected. Outcomes of the
study were target lesion failure (TLR), cardiac death, myocardial infarction (MI), and
clinically driven target vessel revascularization (TVR) up to 3 years.
RESULTS A total of 100 men and 62 women underwent VBT for DES-ISR between
years 2003-2008. Mean age of the 2 groups was similar. Women more often pre-
sented with unstable symptoms (73% vs. 55%). There was no signiﬁcant difference in
the site and length of the lesion treated. Majority of males had previous bypass
grafting (63% vs. 38%); however, women with stented graft presented earlier than
men. (68 months vs. 114 months). Equal rates of procedural success were seen be-
tween the 2 groups; however, women had higher rate of vascular complications (8%
vs. 0%) than men. There was no signiﬁcant difference in the 6 months, 1, 2 and 3
years rates of TLR, TVR, MI and cardiac death (Figure) between men and women.
Both groups showed a time dependent attrition in the stent patency rates during the
3 year follow up.
CONCLUSIONS Although women had more unstable presentation and a higher rate of
vascular complications, procedural success and long terms outcomes were similar
between men and women undergoing VBT for refractory DES-ISR.CRT-167
Impact Of Hemoglobin A1c On Long-term Outcomes Of Drug-eluting Stents And
Bare Metal Stents Differently
Hideki Wada,1 Katsumi Miyauchi,2 Satoru Suwa,1 Hiroyuki Daida2
1Juntendo University, Shizuoka hospital, Izunokuni, Shizuoka, Japan; 2Juntendo
University, Tokyo, Japan
Previous studies showed admission levels of hemoglobin A1c (HbA1c) correlate
with long-term outcomes in patients with bare metal stents. It is uncertain that
HbA1c is associated with an increased risk of cardiovascular events in patients
undergoing DES.
METHODS AND RESULTS This study compared the impact of HbA1c on clinical out-
comes of BMS and DES in a single-center prospective registry. This was an observa-
tional study of 3,492 consecutive patients who underwent PCI between 2000 and
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1,595 patients received DES. Patients were assigned to four groups according to the
quadrant values of admission HbA1c. The primary endpoint was composite of MACE
(all-cause death, ACS and revascularization). The mean follow-up duration was 4.5
years. As ﬁgured showed, the higher the HbA1c, the higher the rate of MACE and ASC
plus death (p<.0001, 0.002) in the BMS group. However, HbA1c showed no such
correlation with MACE and ACS plus death (p ¼ 0.20, 0.69) in the DES group. Multi-
variable Cox regression analysis showed that HbA1c was not associated with long-
term outcomes in DES.
CONCLUSIONS HbA1c has no impact on long-term outcomes of patients implanted
with DES. In contrast, HbA1c correlates with higher MACE rates in BMS group.C
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Comparative Assessment Of The Antirestenotic Efﬁcacy Of Two Paclitaxel Drug-
eluting Balloons With Different Coatings In The Treatment Of In-stent
Restenosis: Results Of The DEB-ISR Study.
Freek Nijhoff,1 Pieter R. Stella,1 Maartje S. Troost,1 Anouar Belkacemi,2
Hendrik M. Nathoe,1 Michiel Voskuil,1 Mariam Samim,1 Pieter A. Doevendans,1
Pierfrancesco Agostoni1
1University Medical Center Utrecht, Utrecht, Netherlands; 2Isala, Zwolle, Netherlands
BACKGROUND Drug-eluting balloons (DEB) have shown effectiveness in the treat-
ment of bare metal and drug-eluting stent in-stent restenosis (ISR). Preclinical in-
vestigations have suggested that coating technology is crucial for the efﬁcacy of DEB.
Aim of this study is to compare the antirestenotic efﬁcacy of two paclitaxel DEB with
different coatings in the treatment of ISR by means of a morphological and functional
assessment.
METHODS In a single center, prospective, non-randomized study, the shellac-pacli-
taxel coated DIOR (EuroCor GmbH, Bonn, Germany) and the urea-paclitaxel coated
IN.PACT Falcon (Medtronic Vascular Inc., Santa Rosa, CA, USA) were compared in the
setting of ISR. Besides quantitative angiography, fractional ﬂow reserve (FFR) and
optical coherence tomography (OCT) were performed at baseline, post-procedure and
6-months follow-up. Main endpoints of the analysis were QCA, FFR and OCT-based
parameters of restenosis.
RESULTS Forty-ﬁve patients were included, 20 (44%) received treatment with the
DIOR and 25 (56%) with the IN.PACT Falcon. Angiographic and device success were
100% and 90% for the DIOR, and 100% and 92% for the IN.PACT Falcon, respec-
tively. At 6-months follow-up, in-segment late lumen loss (-0.030.43 vs.
0.360.48 mm, p¼0.014) and diameter stenosis (30.716.2 vs. 41.322.6%, p¼0.083)
were lower for the IN.PACT Falcon. FFR distal of the stent was signiﬁcantly higher
in the IN.PACT Falcon group (0.920.07 vs. 0.840.13, p¼0.029) and in-stent FFR
gradient was lower (0.050.05 vs. 0.130.12, p¼0.002). Between postprocedure and
follow-up, a 16% decrease in neointimal volume was observed for the IN.PACT
Falcon, while a 30% increase was observed for the DIOR (p¼0.006). Target lesion
revascularization rate was 8% in the IN.PACT Falcon and 30% in the DIOR group
(p¼0.11).
CONCLUSIONS The IN.PACT Falcon DEB showed higher antirestenotic efﬁcacy than
the DIOR in the treatment of ISR, demonstrating that DEB with an excipient based
coating are not equally effective. Comparative assessment of DEB in the clinical
setting is warranted.CRT-169
Impact Of Chronic Alcohol Consumption On 5-year Clinical Outcomes in Patients
with Signiﬁcant Coronary Artery Spasm; A Propensity Score Matching Study
Byoung Geol Choi,1 Seung-Woon Rha,2 Se Yeon Choi,2 Sang-Ho Park,3 Woong Gil Choi,4
Soo Hyun Kim,5 Eun-Gyu Lee,6 Ji Young Park,7 Jihun Ahn,8 Sang Yeub Lee,9
Sang Min Kim,9 Min Woong Kim,10 Seong Gyu Yoon,1 Tae Hoon Ahn,11 Dong Joo Oh2
1Department of Medicine, Korea University Graduate School, Seoul, Korea, Republic of;
2Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea, Republic of;
3Cardiology Department, Soonchunhyang University Cheonan Hospital, Cheonan,
Korea, Republic of; 4Division of Cardiology, Konkuk University Chungju Hospital,
Chungju, Korea, Republic of; 5Division of Cardiology, Konkuk University Chungju
Hospital, chungju, Korea, Republic of; 6Cardiovascular Cencer, Andong Sungso
Hospital, Andong, Korea, Republic of; 7Cardiology Department, Eulji General Hospital,
Seoul, Korea, Republic of; 8Department of Internal Medicine, Soonchunhyang
University Gumi Hospital, Gumi, Korea, Republic of; 9Cardiovascular Center,
Chungbuk National University Hospital, Cheongju, Korea, Republic of; 10Department of
Cardiology, Hanyang University Medical Center, Hanmaeum Hospital, Changwon,
Korea, Republic of; 11Gachon University of Medicine and Science, Gil Hospital, Incheon,
Korea, Republic of
BACKGROUND Chronic alcohol consumption is known to be a risk factor of signiﬁcant
coronary artery disease (CAD). However, currently there is no available data with
larger study population regarding long-term clinical outcomes of CAS patients (pts)
with chronic alcohol consumption in real world clinical practice.
METHODS A total of 3,349 consecutive pts without signiﬁcant coronary artery disease
(CAD) underwent acetylcholine (Ach) provocation test between Nov. 2004 and May.
2014 and positive CAS pts were enrolled. Signiﬁcant CAS was deﬁned as > 70% of
narrowing by incremental intracoronary injection of 20, 50 and 100 mg into left cor-
onary artery. Patients were divided into two groups based on the presence of alcohol
consumption: the Alcoholic group (n¼1,189), the control group (n¼2,160). To adjust
potential confounders, a propensity score matched (PSM) analysis was performed
using the logistic regression model.
RESULTS After PSM analysis, 2 propensity-matched groups (877 pairs, n¼1,754, C-
statistic¼0.796) were generated and the baseline characteristics of the two groups
were balanced. At 5 years, there were similar incidence of individual hard endpoints
including mortality, myocardial infarction, revascularization and recurrent angina
requiring repeat coronary angiography between the two groups.
CONCLUSIONS Despite the expected endothelial dysfunction, chronic alcohol con-
sumption was not associated with worse clinical outcomes in CAS pts up to 5 years,
suggesting that the mechanisms and risk factors of CAS may be different from those of
atherosclerotic CAD.CRT-170
Cardiac Rehabilitation Improves the Ischemic Burden in Patients with Ischemic
Heart Disease who are not Suitable for Revascularization
Salah El Demerdash,1 Hazem Khorshid,1 Iman Salah,1
Mohamed Ahmed Abdel-Rahman,1 Alaa Mabrouk Salem Omar2
1Ain Shams University Hospital, Department of Cardiology, Cairo, Egypt; 2National
Research Centre, Medical Division, Department of Internal Medicine, Cairo, Egypt
BACKGROUND Ischemic heart diseases including stable angina & acute events,
represent a huge burden on both the individual & the society and represents an
important source of disability.
AIM We aimed to identify the effect of cardiac rehabilitation program (CRP) on the
ischemic burden in patients with ischemic heart disease (IHD) unsuitable for coronary
revascularization.
METHODS Forty patients with IHD who were unﬁt for coronary revascularization were
recruited. All patients were subjected to sophisticated CRP protocols, including patient
